Conduent - Pharmaceuticals / Life Sciences Operational Transformation

Conduent - Pharmaceuticals / Life Sciences Operational Transformation

Who is This Vendor Assessment For?

NelsonHall’s pharmaceuticals / life sciences operational transformation profile on Conduent is a comprehensive assessment of Conduent’s offerings and capabilities, designed for:
Sourcing managers monitoring the capabilities of existing suppliers of pharmaceuticals / life sciences operational transformation services and identifying vendor suitability for operational transformation services RFPs
Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
Financial analysts and investors specializing in the pharmaceuticals / life sciences services sector.

Key Findings & Highlights

Conduent, which was spun off from Xerox Business Services in 2017, has solutions targeting payer, provider, pharma & life sciences, and government health services. Within its pharma and life sciences business, Conduent currently offers:
Patient access solutions
Patient and provider engagement solutions
Medical information and clinical trial support.

In 2020, Conduent began to re-invest in the pharma & life sciences business. As a result of these investments, Conduent grew the pharmaceutical and life sciences pipeline seven times vs. 2019.

Scope of the Report

The report provides a comprehensive and objective analysis of Conduent’s pharmaceuticals / life sciences operational transformation offerings and capabilities, and market and financial strengths, including:
Identification of the company’s strategy, emphasis, and new developments
Analysis of the company’s strengths, weaknesses, and outlook
Revenue estimates
Analysis of the profile of the company’s customer base, including the company’s targeting strategy and examples of current contracts
Analysis of the company’s offerings and key service components
Analysis of the company’s delivery organization, including the location of delivery locations.